磁疗手术胆结石的红外光谱观测

本文报道用Nicolet 170 SXFT-IR红外光谱仪观测磁疗手术胆结石、磁疗破碎排出胆结石及服中草药破碎胆结石的红外光谱,分析并比较了它们的光谱特征。     

酞菁锰-表面活性剂薄膜电极的电化学表征及其对三氯乙酸的电化学催化作用的研究

将酞菁锰（ＭｎＰｃ）掺入阳离子表面活性剂双十二烷基二甲基溴化铵（ＤＤＡＢ）的氯仿溶液，并涂布于热解石墨电极表面，待氯仿挥发后即制得ＭｎＰｃ－ＤＤＡＢ薄膜电极。循环伏安实验表明，在ＫＢｒ溶液中，该薄膜电极有两对还原氧化峰，第一对峰的Ｅｐｃ１＝－０．２７Ｖ，Ｅｐａ１＝０．０１Ｖ；第二对峰的Ｅｐｃ２＝－０．７６Ｖ，Ｅｐａ２＝－０．６２Ｖ（ｖｓ．ＳＣＥ）。本文着重探讨了第二对峰的电化学行为，估计了该体系的电荷传递扩散系数Ｄｃｔ和表观非均相电极反应速率常数Ｋ０′等电化学参数，并可将该薄膜电极用于催化三氯乙酸的电化学还原。     

24-亚甲基-胆甾-3β,5α,6β,19-四醇——一种罕见的含19-羟基的多羟基甾醇

从我国西沙群岛采集的软珊瑚Nephthea albida和南沙群岛采集的N.tixiexae uer seueldt的乙醇,抽提物中,通过硅胶层析分离出一种罕见的含19-羟基的多羟基甾醇——Nephalsterol-A(1),该物质为无色针状结晶,m.p.242～243℃,[a]_D~(20)=O(C 0.053,CH_3OH),为一新化合物。 (1)的ELMS显示分子离子峰m/z 448,结合~(13) NMR DEPT谱确定(1)的分子式为C_(28)H_(48)     

Two new compounds from Zingiber officinale

A new cyclic diarylheptanoid,1,5-epoxy-3-hydroxy-1-(3-methoxy-4,5-dihydroxyphenyl)-7-(4-hydroxyphenyl)-heptane (1),as well as a new monoterpene,10-O-β-D-glucopyranosyl-hydroxy cineole (2) were isolated from the rhizomes of Zingiber officinale. The structures of compounds 1 and 2 were established based on their spectral data.In addition,the antioxidant activities of these compounds were also measured.     

头发锌含量测定的应用价值评价

以114例2－5岁儿童为对象，同时取其末梢血和头发，测定锌含量。以全血锌值为标准，评价头锌测定的应用价值。结果显示，头发锌测定的灵敏度可达86．1％，特异度为52．4％，符合率为73．7％。     

A new chemiluminescence reagent for the determination of ruthenium

A new reagent proflavine-N, N, N', N'-tetraacetic acid (PTA) synthesized in our laboratory has been found useful as a chemiluminescence reagent for the determination of ruthenium (Ru) in pH 2.5 sulfuric acid solution containing acetone, it can be oxidized catalytically by hydrogen peroxide. With Ru(III) as catalyst, it emits light selectively. The linear range is between 2.0 x 10(-8) and 2.0 x 10(-5) g/ml. The detection limit and the recovery rate of the method are 1.0 x 10(-9)g/ml and 96.0-102%, respectively. The method has been satisfactorily applied to determine trace Ru(III) in synthesized sample.     

Monitoring photoproduct formation and photobleaching by fluorescence spectroscopy has the potential to improve PDT dosimetry with a verteporfin-like photosensitizer

In current clinical practice, photodynamic therapy (PDT) is carried out with prescribed drug doses and light doses as well as fixed drug-light intervals and illumination fluence rates. This approach can result in undesirable treatment outcomes of either overtreatment or undertreatment because of biological variations between different lesions and patients. In this study, we explore the possibility of improving PDT dosimetry by monitoring drug photobleaching and photoproduct formation. The study involved 60 mice receiving the same drug dose of a novel verteporfin-like photosensitizer, QLT0074, at 0.3 mg/kg body weight, followed by different light doses of 5, 10, 20, 30, 40 or 50 J/cm2 at 686 nm and a fluence rate of 70 mW/cm2. Photobleaching and photoproduct formation were measured simultaneously, using fluorescence spectroscopy. A ratio technique for data processing was introduced to reliably detect the photoproduct formed by PDT on mouse skin in vivo. The study showed that the QLT0074 photoproduct is stable and can be reliably quantified. Three new parameters, photoproduct score (PPS), photobleaching score (PBS) and percentage photobleaching score (PBS%), were introduced and tested together with the conventional dosimetry parameter, light dose, for performance on predicting PDT-induced outcome, skin necrosis. The statistical analysis of experimental results was performed with an ordinal logistic regression model. We demonstrated that both PPS and PBS improved the prediction of skin necrosis dramatically compared to light dose. PPS was identified as the best single parameter for predicting the PDT outcome.     

Fluorescence ratiometric pH sensor prepared from covalently immobilized porphyrin and benzothioxanthene

A fluorescence ratiometric sensor for pH determination is described in this paper. The sensor incorporated the pH-sensitive dye meso-5,10,15,20-tetra-(4-allyloxyphenyl)porphyrin (TAPP) as an indicator and a pH-insensitive dye N-(2-methacryloxyethyl)benzo[k,l]thioxanthene-3,4-dicarboximide (MBTD), a benzothioxanthene derivative, as a reference for fluorescence ratiometric measurement. To prevent leakage of the dyes, both were photocopolymerized with acrylamide, hydroxyethyl methacrylate, and triethylene glycol dimethacrylate on the silanized glass surface. The reproducibility and response time of the prepared sensor were sufficient. Most common coexisting inorganic ions and organic compounds did not interfere with pH sensing. In the acidic pH range from 1.5 to 5.0 the fluorescence intensity ratio of the two dyes varied linearly as a function of pH. The sensing membrane was found to have a lifetime of at least one month. The sensor was applied to the analysis of waste water and artificial samples.     

Hydrothermal Synthesis and Structural Characterization of a Tubular Arsenic-Vanadate: [CoII(2,2′-bpy)2]2[AsIII8VIV14O42(H2O)]·H2O

The hydrothermal reaction of VOSO₄, As₂O₃, CoC₂O₄·2H₂O and 2,2-bipy yields a novel arsenic-vanadate [Co^II(2,2-bpy)₂]₂[As^III₈V^IV ₁₄O₄₂(H₂O)]·H₂O (1), which is characterized by IR, elemental analysis, TGA, magnetic susceptibility and single crystal X-ray diffraction analysis. X-ray diffraction shows that compound 1 is the first example of tubular arsenic–vanadium cluster containing infinite {[Co(2,2-bpy)₂]₂[As₈V₁₄O₄₂(H₂O)]} chain constructed from [As₈V₁₄O₄₂(H₂O)] clusters interconnected through [Co(2,2-bpy)]²⁺ units. Crystal data: 1, orthorhombic, P 2₁2₁2₁, a=12.1401(2) Å, b=15.8722(1) Å, c=39.9533(5) Å, Z=4.Graphical Abstract: A novel polyoxoarsenicvanadate, [Co^II(2,2-bipy)₂]₂ [As^III₈V^IV ₁₄O₄₂(H₂O)]·H₂O, is depicted along with a tubular hybrid solid with a rhombic tube formed within the chain.     

Lysophosphatidic acid induces astrocyte proliferation in hippocampus slices partially through activating extracellular signal-regulated kinases

The goal of the present study is to test the hypothesis that LPA induces proliferation of astrocytes in hippocampus in vivo via phosphorylation of ERK 1/2. We first characterized the expression of GFAP, a special marker fiber protein of astrocytes, in brain slices after direct injection of LPA into hippocampus by immunohistochemistry, and found that LPA induced a remarkable proliferation of astrocytes. Then double-lablled immunofluorescence was used to detect GFAP and phosphorylation ERK 1/2 (p-ERK 1/2), LPA induced an immediate (10 min) and transient (<30 min) phosphorylation of ERK 1/2, and sequence sustained activation of ERK 1/2 was observed, which last for at least 3 weeks after injection of LPA. Reactions are inhibited by U0126, a specific pharmacological mitogen-activated protein kinase (MEK) inhibitor. Laser confocal scanning was used to study spatial relationship of p-ERK and astrocytes. Amazingly, the early (<7 days) phosphorylation of ERK 1/2 is not expressed in astrocytes but in area where neurons and/or in other cell type(s) occupied, expression of p-ERK 1/2 in astrocytes is not detected until 14 days after LPA injection and lasts for at least 3 weeks. Taken together, these data suggest that LPA play an important role in proliferation of astrocytes through phosphorylation of ERK 1/2 in hippocampus. It provides further proof for the functions of LPA in CNS injury, and may contribute to clinical therapy for relative diseases.